Cannara Biotech Inc. (TSX:LOVE)
Canada · Delayed Price · Currency is CAD 1.880
-0.040 (-2.08%)
Aug 10, 2026, 10:30 AM EST
Cannara Biotech Financials Overview
Financials in millions CAD. Fiscal year is September - August.
Millions CAD. Fiscal year is Sep - Aug.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Revenue Revenue Growth | 117.45 | 107.32 | 82.15 | 57.56 | 36 | 17.27 |
Revenue Growth | 14.66% | 30.64% | 42.71% | 59.91% | 108.48% | 723.43% |
Gross Profit Gross Profit Growth | 50.09 | 47.22 | 30.19 | 27.53 | 17.49 | 10.54 |
Operating Income Operating Income Growth | 18.66 | 22.2 | 10.08 | 11.89 | 4.94 | 0.26 |
Net Income Net Income Growth | 10.86 | 13.08 | 6.44 | 6.95 | 2.31 | -1.53 |
Earnings Per Share EPS Growth | 0.11 | 0.14 | 0.07 | 0.08 | 0.03 | -0.10 |
EPS Growth | -35.29% | 100.00% | -12.50% | 166.67% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Cannabis Operations Cannabis Operations Growth | 112.77 | 103.02 | 77.63 | 53.48 | 32.61 | 13.97 |
Real Estate Operations Real Estate Operations Growth | 3.93 | 3.84 | 4.02 | 3.59 | 3.37 | 3.12 |
Total Total Growth | 116.7 | 106.86 | 81.65 | 57.07 | 36 | 17.27 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Cash & Investments Cash & Investments Growth | 21.81 | 14.36 | 6.62 | 4.27 | 12.11 | 8.16 |
Total Debt Total Debt Growth | 37 | 41.58 | 48.33 | 45.78 | 48.39 | 20.89 |
Net Cash (Debt) Net Cash Growth | -15.19 | -27.22 | -41.71 | -41.51 | -36.28 | -12.73 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.16 | -0.29 | -0.46 | -0.46 | -0.41 | -0.17 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 19.42 | 20.01 | 10.68 | 5.91 | -6.08 | -2.09 |
Capital Expenditures CapEx Growth | -13.72 | -6.36 | -7.47 | -9.88 | -15.47 | -31.07 |
Free Cash Flow Free Cash Flow Growth | 5.69 | 13.65 | 3.21 | -3.97 | -21.55 | -33.17 |
Free Cash Flow Growth | -62.01% | 324.86% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Gross Margin | 42.65% | 44.00% | 36.75% | 47.83% | 48.58% | 61.06% |
Operating Margin | 15.89% | 20.68% | 12.27% | 20.65% | 13.73% | 1.49% |
Pretax Margin | 13.86% | 16.86% | 5.46% | 12.07% | 6.40% | -8.85% |
Profit Margin | 9.25% | 12.18% | 7.84% | 12.07% | 6.40% | -8.85% |
FCF Margin | 4.85% | 12.72% | 3.91% | -6.89% | -59.85% | -192.08% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 10, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
PE Ratio | 17.46 | 12.86 | 9.71 | 12.50 | 45.00 | - |
Forward PE | 10.52 | 12.41 | - | - | - | - |
P/FCF Ratio | 33.31 | 11.98 | 19.05 | - | - | - |
PS Ratio | 1.62 | 1.52 | 0.75 | 1.57 | 3.29 | 8.63 |